Conference Notifications:
"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."
Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in
Beersheba. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Beersheba event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Beersheba conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Beersheba, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Beersheba."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
Innovations in Immune Checkpoint Inhibitors
This track will explore the latest advancements in immune checkpoint inhibitors, focusing on their mechanisms of action and clinical applications. Participants will discuss novel combinations and strategies to enhance therapeutic efficacy in various cancer types.
CAR-T Cell Therapy: Current Trends and Future Directions
This session will delve into the development and optimization of CAR-T cell therapies, highlighting recent clinical trial outcomes and challenges. Discussions will also cover the potential for expanding CAR-T applications beyond hematological malignancies.
Monoclonal Antibodies in Cancer Treatment
This track will examine the role of monoclonal antibodies in cancer immunotherapy, including their mechanisms of action and therapeutic applications. Participants will analyze recent clinical data and emerging trends in antibody engineering.
Immune Modulation Strategies in Oncology
This session will focus on various immune modulation strategies aimed at enhancing anti-tumor responses. Topics will include the use of cytokines, immune adjuvants, and novel agents that can reshape the tumor microenvironment.
Adoptive Cell Therapy: Challenges and Innovations
This track will address the current challenges in adoptive cell therapy, including T cell exhaustion and persistence. Innovations in cell engineering and the use of novel cellular products will also be discussed.
Cytokine Therapy: Mechanisms and Applications
This session will explore the role of cytokines in modulating immune responses, with a focus on their therapeutic potential in cancer treatment. Participants will review recent findings on cytokine-based therapies and their clinical implications.
Translational Research in Immuno-Oncology
This track will highlight the importance of translational research in bridging laboratory findings with clinical applications in immuno-oncology. Discussions will focus on the identification of immune biomarkers and their role in patient stratification.
Clinical Trials in Immunotherapy: Design and Outcomes
This session will provide insights into the design and execution of clinical trials for immunotherapeutic agents. Participants will discuss challenges in trial design, patient recruitment, and the interpretation of outcomes.
Immune Biomarkers: Predicting Response and Resistance
This track will focus on the identification and validation of immune biomarkers that can predict patient responses to immunotherapy. Discussions will include the implications of these biomarkers for personalized treatment approaches.
Immune Tolerance and Regulation in Cancer
This session will explore the mechanisms of immune tolerance and regulation that tumors exploit to evade immune detection. Participants will discuss potential therapeutic strategies to overcome these barriers.
Therapeutic Vaccines: Development and Challenges
This track will examine the development of therapeutic vaccines aimed at eliciting robust anti-tumor immune responses. Challenges in vaccine design, delivery, and patient response will be critically analyzed.